CHRISTY EVANS: Open Payments
NPI 1336560903 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 44 payments from 13 companies in 2025. Trend: 2023 $717 · 2024 $1,422 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 5 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $129 |
| Lilly USA, LLC | 13 | $116 |
| BETA BIONICS, INC. | 4 | $97 |
| CeQur Corporation | 1 | $83 |
| Dexcom, Inc. | 3 | $72 |
| Abbott Laboratories | 3 | $57 |
| Tandem Diabetes Care, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $29 |
| ABBVIE INC. | 1 | $17 |
Products named: Omnipod, JARDIANCE, MOUNJARO, iLet Bionic Pancreas, CeQur Simplicity, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across SC — which companies pay providers there.
